{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:28:34Z","timestamp":1771493314372,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.amjcard.2020.06.046","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T02:25:21Z","timestamp":1593483921000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study)"],"prefix":"10.1016","volume":"131","author":[{"given":"Andreas","family":"Goette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron-Ariel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.06.046_bib0001","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2014.11.035","article-title":"Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation","volume":"128","author":"Hsu","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0003","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(16)31474-X","article-title":"Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial","volume":"388","author":"Goette","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0004","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0006","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0007","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","article-title":"Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles","volume":"30","author":"Goette","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0008","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2017.07.033","article-title":"CREM-transgene mice: an animal model of atrial fibrillation and thrombogenesis","volume":"163","author":"Bukowska","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ahj.2017.07.010","article-title":"The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study","volume":"193","author":"Lip","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0010","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/europace\/euz213","article-title":"Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis","volume":"21","author":"Merino","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0011","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/europace\/euz292","article-title":"The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events","volume":"22","author":"Atar","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1871529X17666170104120746","article-title":"Biomarker assays for personalised stroke risk assessment in atrial fibrillation","volume":"17","author":"Hall","year":"2017","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0014","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvw022","article-title":"Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score","volume":"3","author":"Overvad","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0017","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0018","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0019","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphys.2012.00236","article-title":"Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation","volume":"3","author":"Goette","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1476-5381.2011.01784.x","article-title":"Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs","volume":"166","author":"Bukowska","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0021","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/01.CIR.0000039327.11661.16","article-title":"Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke","volume":"106","author":"Cai","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0002-9149(01)01905-1","article-title":"Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation","volume":"88","author":"Goette","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0023","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000102968.19341.FC","article-title":"Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?","volume":"108","author":"Goette","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.06.046_bib0024","article-title":"Serum fatty acid binding proteins as a potential biomarker in atrial fibrillation","volume":"70","author":"Golaszewska","year":"2019","journal-title":"J Physiol Pharmacol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920306238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920306238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:34:24Z","timestamp":1757572464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920306238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":24,"alternative-id":["S0002914920306238"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.06.046","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}